FDA Approves First Medical Device for Obesity Treatment Targeting Brain-to-Stomach Signaling

DietarySupplements (#1) 1689 days ago Weight Loss fda approves medical device obesity treatment targeting brain-to-stomach signaling All   Discuss  | Add To 
The United States Food and Drug Administration (FDA) approved EnteroMedic's VBLOC(r) vagal blocking therapy, delivered via the Maestro(r) System, which is the first medical device approved for obesity treatment that targets the nerve pathway between the brain and the stomach. The Obesity Society calls this a "a novel device that interrupts signals from the stomach to the brain that are believed to be involved with stomach emptying and feelings of fullness."

Advertise With Us!

Dietary Supplement & Health Search Engine

Dietary Supplement Reviews from users worldwide. Get up to date dietary supplement information from name brand dietary supplement makers at

Featured Supplements

Advertise With Us!